Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab
Laurence De Davide1, Annie Beaudoin1
1Department of Gastroenterology, Sherbrooke University Hospital Center, Sherbrooke, QC, Canada.
Abstract:
Phlegmonous gastritis is a pyogenic infection affecting the submucosa of the gastric wall. Although rarely diagnosed, it remains a disease with high mortality. We thereby describe the case of a 42-year-old male patient known for psoriatic arthritis on Infliximab who was diagnosed with phlegmonous gastritis secondary to immunosuppressive therapy. The patient had a favourable outcome with a conservative treatment consisting of a 14-day course of broad antibiotherapy.
Insights
Phlegmonous gastritis, a rare but deadly infection, can occur secondary to immunosuppressive therapy. This case highlights a favorable outcome with conservative antibiotic treatment in an immunosuppressed patient.
Area of Science:
- Gastroenterology
- Immunology
- Infectious Diseases
Background:
- Phlegmonous gastritis is a severe submucosal gastric infection with high mortality.
- Immunosuppressive therapy, used for conditions like psoriatic arthritis, can increase infection risk.
Observation:
- A 42-year-old male with psoriatic arthritis on Infliximab presented with symptoms suggestive of phlegmonous gastritis.
- The patient's condition was attributed to immunosuppressive therapy.
Findings:
- Diagnosis of phlegmonous gastritis was confirmed.
- The patient received a 14-day course of broad-spectrum antibiotics.
Implications:
- Conservative antibiotic therapy can be effective for phlegmonous gastritis in immunosuppressed patients.
- Early diagnosis and treatment are crucial for improving outcomes in this rare condition.
More Related Videos
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
03:48Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Patient-centered Care
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients